BSE filing, NSE: EXPLEOSOL. Summary written from the filing by ALFA Finder's alert engine.
Expleo Solutions Ltd: key numbers
- Share price
- ₹822.40
- Market cap
- ₹1,276 Cr
- Revenue (annual)
- ₹1,108 Cr
- Net profit (annual)
- ₹124.0 Cr
- P/E (TTM)
- 9.3×Sector 23.4×
- Promoter holding
- 71.05%+0.00% QoQ
- FII holding
- 0.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Expleo Solutions Ltd
All →Expleo Solutions Annual General Meeting
Expleo Solutions' postal ballot on loan limits for related parties by wholly owned subsidiaries failed to get the requisite majority. The scrutinizer's report confirmed the ordinary resolution was not passed.
Expleo Solutions Other Announcement
Expleo Solutions Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Expleo Solutions Merger & Restructuring Worth ₹2.1 Cr
Expleo Solutions Limited invested Rs.2.10 Crore in its wholly owned subsidiary, Expleo Solutions GIFT IFSC Limited. The subsidiary also received its Certificate of Registration from IFSCA.
- Value
- ₹2.10 Cr
Expleo Solutions Annual General Meeting
Expleo Solutions Limited has issued a postal ballot notice seeking shareholder approval for a related party transaction. The resolution proposes a loan limit of Rs. 280 Crore for subsidiaries.
- Value
- ₹280.0 Cr
- Execution
- FY 2026-27 onwards
Expleo Solutions Annual General Meeting
Expleo Solutions Limited approved a draft postal ballot notice, fixed the cut-off date as September 26, 2026, and appointed a scrutinizer for the e-voting process.
Expleo Solutions Price Movement Clarification
Expleo Solutions Limited clarified that the recent spurt in share trading volume is purely market-driven. The company confirmed no undisclosed price-sensitive information is pending.
Other board meeting date announcements
All →Escorp Asset Management Board Meeting Date
Escorp Asset Management Limited will hold a board meeting on November 12, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
SBEC Systems (India) Board Meeting Date
SBEC Systems India Ltd has scheduled a board meeting for November 13, 2026. The board will consider unaudited standalone and consolidated financial results for the quarter ended September 2026.
Oxygenta Pharmaceutical Board Meeting Date
Oxygenta Pharmaceutical Limited has scheduled a board meeting for November 10, 2026. The board will primarily consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Aries Agro Board Meeting Date
Aries Agro Limited scheduled a Board Meeting for November 13, 2026. The board will consider un-audited standalone and consolidated financial results for the quarter ended September 30, 2026.
Kavveri Defence & Wireless Technologies Board Meeting Date
Kavveri Defence & Wireless Technologies has scheduled a board meeting for November 14, 2026. The board will consider half-yearly unaudited financial results for September 2026.
Dilip Buildcon Board Meeting Date
Dilip Buildcon's board will meet on November 12, 2026, to approve un-audited standalone and consolidated financial results. The trading window remains closed for all designated persons and insiders.